Opus Genetics (IRD) EBT (2022 - 2024)
Opus Genetics (IRD) has disclosed EBT for 6 consecutive years, with -$40.4 million as the latest value for Q4 2021.
- On a quarterly basis, EBT changed N/A to -$40.4 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$56.7 million, a N/A change, with the full-year FY2022 number at $18.2 million, up 132.11% from a year prior.
- EBT was -$40.4 million for Q4 2021 at Opus Genetics, down from -$1.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$40.4 million in Q4 2021 to a low of -$40.4 million in Q4 2021.